Actym

Actym Therapeutics is a cutting-edge biotechnology company focused on the discovery and development of novel immuno-oncology therapies. Actym Therapeutics is committed to researching hard-to-treat immune pathways in the tumor microenvironment and has discovered a STING pathway agonist, which has demonstrated potent anti-tumor efficacy in various murine cancer models.